首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Treatment of acute hepatitis C virus infection with interferon-α 2b and ribavirin: Case report and review of the literature
【24h】

Treatment of acute hepatitis C virus infection with interferon-α 2b and ribavirin: Case report and review of the literature

机译:干扰素-α2b和利巴韦林治疗急性丙型肝炎病毒感染:病例报告及文献复习

获取原文
           

摘要

Hepatitis C virus (HCV) infection becomes chronic in about 85 % of individuals as demonstrated by the persistence of HCV. It is necesseray to treat acute hepatitis C infection. Interferon-α is generally used for the treatment of acute HCV infection. Case presentation A 55-year-old woman with a history of fatique and icter was diagnosed as acute hepatitis C virus infection. She was treated with interferon-α 2b 3 million unite sc three times in a week and ribavirin 1000 mg daily for 6 months. Within 2 weeks of therapy, the alanine aminotransferase (ALT) had became normal. At the end of the 3 months of therapy, HCV RNA was negative and remained negative 6 months after the end of interferon treatment (sustained response). Conclusion This report suggests that interferon-α 2b and ribavirin may have a role in treatment of acute hepatitis C virus infection.
机译:丙型肝炎病毒的持续存在证明,丙型肝炎病毒(HCV)感染在约85%的个体中呈慢性。有必要治疗急性丙型肝炎感染。干扰素-α通常用于治疗急性HCV感染。病例介绍一名55岁的女性,曾因疲劳和黄疸病被诊断为急性丙型肝炎病毒感染。一周接受3次干扰素-α2b 300万单位sc治疗,每天服用1000毫克利巴韦林治疗6个月。在治疗的2周内,丙氨酸转氨酶(ALT)变得正常。在治疗的3个月结束时,HCV RNA阴性,在干扰素治疗结束6个月后仍保持阴性(持续应答)。结论该报告提示干扰素-α2b和利巴韦林可能在急性丙型肝炎病毒感染的治疗中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号